Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US7285531B1 · kind B1 · utility
2Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Oct 23, 2007 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention involves prophylaxis or treatment of nervous system pathological conditions. This is accomplished by administering secretable glial growth factors, such as the molecule referred to as GGF-2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.